INCLISIRAN

INCLISIRAN was reported 8446 times

INCLISIRAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APOLIPOPROTEIN B DECREASED 12 0.8000
1 APOLIPOPROTEIN E INCREASED 3 0.7500
2 SPLEEN ISCHAEMIA 11 0.5500
3 CARBOHYDRATE TOLERANCE INCREASED 2 0.4000
4 APOLIPOPROTEIN A-I INCREASED 3 0.3333
5 APOLIPOPROTEIN B INCREASED 11 0.2973
6 LERICHE SYNDROME 16 0.1778
7 ISCHAEMIC NEPHROPATHY 12 0.1558
8 LIPOPROTEIN (A) DECREASED 4 0.1481
9 PREALBUMIN INCREASED 3 0.1364
10 LIPOPROTEIN (A) INCREASED 43 0.1315
11 LOW DENSITY LIPOPROTEIN 8 0.1176
12 APOLIPOPROTEIN A-I DECREASED 3 0.1154
13 LIPOPROTEIN INCREASED 4 0.0851
14 LIPIDS DECREASED 7 0.0753
15 PERIPHERAL ARTERY BYPASS 10 0.0752
16 LOW DENSITY LIPOPROTEIN DECREASED 102 0.0720
17 CREATINE KINASE MB INCREASED 2 0.0714
18 LOW DENSITY LIPOPROTEIN INCREASED 529 0.0683
19 DEHISCENCE 11 0.0582
20 LOW DENSITY LIPOPROTEIN ABNORMAL 34 0.0555
21 HIGH DENSITY LIPOPROTEIN ABNORMAL 12 0.0511
22 ULNAR NERVE INJURY 11 0.0456
23 ABNORMAL ORGAN GROWTH 2 0.0455
24 GLYCOSYLATED HAEMOGLOBIN 8 0.0452
25 BLOOD CHOLESTEROL DECREASED 83 0.0445
26 CAROTID INTIMA-MEDIA THICKNESS INCREASED 2 0.0444
27 IMMOBILISATION SYNDROME 9 0.0423
28 HIGH DENSITY LIPOPROTEIN INCREASED 37 0.0372
29 CREATINE KINASE INCREASED 28 0.0364
30 VASCULAR STENT STENOSIS 14 0.0333
31 MORPHOEA 16 0.0331
32 BLOOD TRIGLYCERIDES DECREASED 11 0.0326
33 VERY LOW DENSITY LIPOPROTEIN INCREASED 7 0.0315
34 MEAN CELL HAEMOGLOBIN CONCENTRATION ABNORMAL 5 0.0311
35 TYPE IIA HYPERLIPIDAEMIA 7 0.0299
36 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 8 0.0296
37 BILE ACIDS INCREASED 5 0.0282
38 RENAL HYPERTENSION 8 0.0257
39 BLOOD TRIGLYCERIDES 2 0.0256
40 CHRONIC HEPATITIS C 8 0.0203
41 MUSCLE DISCOMFORT 14 0.0178
42 CEREBRAL VASCULAR OCCLUSION 2 0.0174
43 HIGH DENSITY LIPOPROTEIN DECREASED 55 0.0165
44 SERUM FERRITIN ABNORMAL 5 0.0156
45 WAIST CIRCUMFERENCE INCREASED 16 0.0154
46 CELLULITIS GANGRENOUS 3 0.0152
47 ALBUMIN GLOBULIN RATIO INCREASED 2 0.0146
48 BLOOD TRIGLYCERIDES ABNORMAL 12 0.0137
49 GRAFT COMPLICATION 8 0.0136
50 AUTOIMMUNE MYOSITIS 6 0.0127
51 INDURATION 20 0.0112
52 BLOOD TRIGLYCERIDES INCREASED 197 0.0111
53 LIPIDS ABNORMAL 8 0.0110
54 LIPIDS INCREASED 21 0.0104
55 RETICULOCYTE COUNT INCREASED 8 0.0099
56 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 37 0.0091
57 BLOOD CHOLESTEROL ABNORMAL 41 0.0089
58 BASAL GANGLIA INFARCTION 3 0.0087
59 ELECTROCARDIOGRAM Q WAVE ABNORMAL 2 0.0085
60 ALBUMIN URINE PRESENT 3 0.0079
61 PRODUCT ADMINISTERED BY WRONG PERSON 3 0.0079
62 NEUROPATHIC ARTHROPATHY 5 0.0077
63 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 4 0.0074
64 DISCHARGE 10 0.0072
65 BILE ACID MALABSORPTION 2 0.0071
66 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 9 0.0070
67 BLOOD HOMOCYSTEINE INCREASED 3 0.0070
68 BLOOD URIC ACID INCREASED 40 0.0069
69 BLISTER RUPTURE 5 0.0067
70 CREATININE URINE INCREASED 2 0.0066
71 CORONARY ARTERY STENOSIS 33 0.0066
72 INJECTION SITE RASH 198 0.0064
73 PRODUCT TEMPERATURE EXCURSION ISSUE 33 0.0064
74 PERIPHERAL ARTERY OCCLUSION 9 0.0064
75 INJECTION SITE EXFOLIATION 4 0.0060
76 RENAL INFARCT 8 0.0055
77 URTICARIA CHRONIC 3 0.0053
78 CAROTID BRUIT 2 0.0052
79 BLADDER PERFORATION 2 0.0052
80 CORONARY ARTERY RESTENOSIS 3 0.0050
81 BLOOD CHOLESTEROL INCREASED 234 0.0050
82 AORTIC OCCLUSION 2 0.0049
83 CAROTID ARTERIOSCLEROSIS 5 0.0048
84 ARTHRITIS REACTIVE 3 0.0048
85 CORTISOL INCREASED 3 0.0048
86 OBSTRUCTIVE SLEEP APNOEA SYNDROME 7 0.0048
87 INJECTION SITE HYPERSENSITIVITY 15 0.0048
88 MITRAL VALVE CALCIFICATION 3 0.0047
89 ARTERIAL STENOSIS 4 0.0046
90 PROTEIN TOTAL INCREASED 12 0.0045
91 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 2 0.0045
92 PARANEOPLASTIC SYNDROME 3 0.0044
93 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2 0.0044
94 HEPATIC FIBROSIS 15 0.0044
95 SPINAL STENOSIS 18 0.0044
96 STENOSIS 8 0.0043
97 ARTERIOSCLEROSIS 40 0.0042
98 FACIAL DISCOMFORT 3 0.0042
99 BLOOD CHOLESTEROL 2 0.0042
100 MYALGIA 706 0.0041
101 RED BLOOD CELL COUNT ABNORMAL 6 0.0041
102 SPLENIC INFARCTION 7 0.0040
103 FEAR OF DEATH 9 0.0040
104 MYOPATHY 34 0.0039
105 INJECTION SITE PARAESTHESIA 6 0.0039
106 RESPIRATORY TRACT IRRITATION 4 0.0038
107 CARBOHYDRATE ANTIGEN 19-9 INCREASED 2 0.0038
108 CORONAVIRUS INFECTION 25 0.0038
109 INJECTION RELATED REACTION 6 0.0036
110 INJECTION SITE VESICLES 22 0.0036
111 CARDIAC DISCOMFORT 7 0.0035
112 NECROTISING MYOSITIS 3 0.0035
113 ADRENAL ADENOMA 2 0.0034
114 INJECTION SITE DISCOMFORT 35 0.0033
115 INJECTION SITE DRYNESS 3 0.0033
116 INTERVERTEBRAL DISC DISORDER 14 0.0033
117 GLOMERULONEPHRITIS 8 0.0033
118 BLADDER DISCOMFORT 4 0.0032
119 INJECTION SITE ULCER 3 0.0032
120 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
121 INJECTION SITE REACTION 215 0.0031
122 MUSCLE FATIGUE 13 0.0031
123 DELIVERY 2 0.0030
124 BRONCHITIS VIRAL 2 0.0030
125 ANGINA UNSTABLE 19 0.0029
126 THYROID HORMONES INCREASED 3 0.0029
127 BLOOD BILIRUBIN UNCONJUGATED INCREASED 2 0.0028
128 CONCOMITANT DISEASE AGGRAVATED 17 0.0028
129 GLYCOSYLATED HAEMOGLOBIN INCREASED 65 0.0026
130 DRUG EFFECT LESS THAN EXPECTED 38 0.0026
131 ACUTE CORONARY SYNDROME 21 0.0025
132 PRODUCT STORAGE ERROR 219 0.0025
133 SKULL FRACTURE 4 0.0025
134 DYSLIPIDAEMIA 12 0.0024
135 WOUND COMPLICATION 8 0.0023
136 CARDIAC VENTRICULAR THROMBOSIS 3 0.0023
137 AMYLOIDOSIS 4 0.0023
138 GAMMA-GLUTAMYLTRANSFERASE INCREASED 51 0.0023
139 CAROTID ARTERY STENOSIS 8 0.0023
140 MUSCULOSKELETAL DISCOMFORT 39 0.0023
141 BLOOD LOSS ANAEMIA 5 0.0022
142 ARTHRALGIA 908 0.0022
143 IMMUNE-MEDIATED MYOSITIS 6 0.0022
144 ANGINA PECTORIS 62 0.0022
145 INJECTION SITE CELLULITIS 4 0.0022
146 DISCOURAGEMENT 5 0.0021
147 THERAPY NON-RESPONDER 96 0.0021
148 HEPATIC PAIN 9 0.0021
149 LOWER RESPIRATORY TRACT INFECTION 94 0.0021
150 IMMOBILE 9 0.0021
151 MUSCLE RUPTURE 8 0.0021
152 INJECTION SITE PRURITUS 137 0.0020
153 DEVICE SAFETY FEATURE ISSUE 2 0.0020
154 INJECTION SITE INFLAMMATION 10 0.0020
155 INJECTION SITE DISCOLOURATION 25 0.0020
156 SUDDEN HEARING LOSS 4 0.0020
157 ACUTE MYOCARDIAL INFARCTION 58 0.0020
158 PERIPHERAL ISCHAEMIA 8 0.0020
159 INJECTION SITE PAIN 600 0.0020
160 ORAL MUCOSAL ERUPTION 3 0.0020
161 VENTRICULAR ARRHYTHMIA 7 0.0019
162 BLOOD CREATINE PHOSPHOKINASE INCREASED 55 0.0019
163 GASTROINTESTINAL PAIN 21 0.0019
164 BRONCHITIS 141 0.0019
165 HEPATITIS E 3 0.0019
166 PHARYNGEAL PARAESTHESIA 3 0.0019
167 BLOOD POTASSIUM ABNORMAL 5 0.0019
168 CYSTITIS INTERSTITIAL 3 0.0019
169 SHOULDER FRACTURE 3 0.0018
170 PROTEIN URINE PRESENT 9 0.0018
171 ARTHROPOD STING 3 0.0018
172 LIMB DISCOMFORT 55 0.0018
173 INFARCTION 12 0.0018
174 EXERCISE TOLERANCE DECREASED 10 0.0017
175 SERUM FERRITIN DECREASED 3 0.0017
176 ADMINISTRATION SITE PAIN 2 0.0017
177 PAIN IN EXTREMITY 510 0.0017
178 HYPOPNOEA 6 0.0017
179 MUSCLE DISORDER 14 0.0017
180 BRAIN FOG 27 0.0017
181 TENDON PAIN 13 0.0017
182 SINUS PAIN 4 0.0017
183 POLYMYOSITIS 3 0.0017
184 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
185 LIVER FUNCTION TEST INCREASED 36 0.0017
186 PULMONARY CONGESTION 22 0.0017
187 SPONDYLITIS 6 0.0016
188 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
189 NEURALGIA 40 0.0016
190 SINUS NODE DYSFUNCTION 3 0.0016
191 CARDIAC DYSFUNCTION 6 0.0016
192 CORONARY ARTERY OCCLUSION 22 0.0016
193 BLOOD CREATININE DECREASED 5 0.0016
194 IMMUNE SYSTEM DISORDER 21 0.0016
195 MOVEMENT DISORDER 51 0.0016
196 POLYMYALGIA RHEUMATICA 5 0.0016
197 ARTERIAL DISORDER 3 0.0016
198 SPINAL PAIN 18 0.0015
199 INJECTION SITE ERYTHEMA 187 0.0015
200 ATRIOVENTRICULAR BLOCK COMPLETE 10 0.0015
201 MYOCARDIAL ISCHAEMIA 17 0.0015
202 OVERWEIGHT 8 0.0015
203 BODY MASS INDEX INCREASED 2 0.0015
204 CARBON DIOXIDE INCREASED 2 0.0015
205 MUSCLE SPASMS 268 0.0015
206 OROPHARYNGEAL DISCOMFORT 13 0.0014
207 ADVERSE REACTION 19 0.0014
208 ELECTRIC SHOCK SENSATION 4 0.0014
209 EMBOLIC STROKE 5 0.0014
210 INJECTION SITE WARMTH 29 0.0014
211 CONNECTIVE TISSUE DISORDER 2 0.0014
212 ASPARTATE AMINOTRANSFERASE INCREASED 74 0.0014
213 MUSCLE TWITCHING 32 0.0014
214 BLOOD ALBUMIN DECREASED 11 0.0014
215 VITREOUS DETACHMENT 3 0.0014
216 ALANINE AMINOTRANSFERASE INCREASED 84 0.0014
217 ENDOMETRIAL CANCER 3 0.0014
218 ARTERIOSCLEROSIS CORONARY ARTERY 9 0.0014
219 CORONARY ARTERY DISEASE 41 0.0014
220 CARDIAC FAILURE ACUTE 9 0.0013
221 AXILLARY PAIN 2 0.0013
222 CALCINOSIS 3 0.0013
223 MYOSITIS 12 0.0013
224 DRUG INTOLERANCE 129 0.0013
225 PHARYNGEAL SWELLING 13 0.0013
226 MITRAL VALVE INCOMPETENCE 15 0.0013
227 AORTIC ANEURYSM 10 0.0013
228 DIABETES MELLITUS 99 0.0013
229 ARTHRITIS 102 0.0013
230 COAGULATION TIME PROLONGED 2 0.0013
231 BILIRUBIN CONJUGATED INCREASED 3 0.0013
232 ENTHESOPATHY 2 0.0013
233 PROSTATOMEGALY 5 0.0013
234 BLADDER PAIN 4 0.0013
235 NECROSIS 7 0.0013
236 INFLUENZA LIKE ILLNESS 103 0.0013
237 COLD SWEAT 22 0.0012
238 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
239 BRONCHITIS CHRONIC 3 0.0012
240 DIVERTICULITIS 34 0.0012
241 TRIGGER FINGER 5 0.0012
242 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
243 TROPONIN INCREASED 9 0.0012
244 INJECTION SITE IRRITATION 15 0.0012
245 BOWEL MOVEMENT IRREGULARITY 9 0.0012
246 LIPASE INCREASED 9 0.0012
247 HEPATIC ENZYME INCREASED 80 0.0012
248 UTERINE HAEMORRHAGE 5 0.0012
249 NEPHROTIC SYNDROME 8 0.0012
250 AORTIC ARTERIOSCLEROSIS 3 0.0012
251 CERVICAL SPINAL STENOSIS 2 0.0012
252 BLOOD CHLORIDE INCREASED 2 0.0012
253 LIPOMA 3 0.0012
254 SWOLLEN TONGUE 36 0.0012
255 FIBROMYALGIA 28 0.0012
256 ARTERIAL OCCLUSIVE DISEASE 9 0.0011
257 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
258 HYPOACUSIS 49 0.0011
259 URINARY TRACT INFECTION 193 0.0011
260 AORTIC VALVE STENOSIS 2 0.0011
261 WEIGHT BEARING DIFFICULTY 3 0.0011
262 SKIN DISCOMFORT 3 0.0011
263 MUSCLE ATROPHY 14 0.0011
264 URINE ABNORMALITY 5 0.0011
265 BODY TEMPERATURE ABNORMAL 2 0.0011
266 BLOOD THYROID STIMULATING HORMONE ABNORMAL 2 0.0011
267 CARDIAC FLUTTER 7 0.0011
268 FOOT DEFORMITY 12 0.0011
269 HEPATIC STEATOSIS 20 0.0011
270 GASTRITIS EROSIVE 5 0.0011
271 SKIN REACTION 15 0.0011
272 ILLNESS 109 0.0011
273 RHINORRHOEA 68 0.0011
274 THYROID MASS 4 0.0010
275 BONE PAIN 61 0.0010
276 ATRIOVENTRICULAR BLOCK 8 0.0010
277 CARCINOEMBRYONIC ANTIGEN INCREASED 2 0.0010
278 INJECTION SITE SWELLING 79 0.0010
279 JOINT STIFFNESS 27 0.0010
280 PULMONARY PAIN 3 0.0010
281 AUTOIMMUNE DISORDER 10 0.0010
282 VITAMIN D DEFICIENCY 10 0.0010
283 HYPERTRIGLYCERIDAEMIA 6 0.0010
284 CONCOMITANT DISEASE PROGRESSION 2 0.0010
285 NECK INJURY 3 0.0010
286 URINE ODOUR ABNORMAL 6 0.0010
287 BACK PAIN 237 0.0010
288 LIVER INJURY 25 0.0010
289 C-REACTIVE PROTEIN INCREASED 37 0.0010
290 VARICES OESOPHAGEAL 3 0.0010
291 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
292 MYASTHENIA GRAVIS 8 0.0010
293 PROSTATITIS 3 0.0010
294 BREAST DISORDER 2 0.0010
295 RECTAL CANCER 3 0.0010
296 MENISCUS INJURY 6 0.0010
297 CHANGE OF BOWEL HABIT 2 0.0010
298 TENDON RUPTURE 12 0.0010
299 MUSCULAR WEAKNESS 110 0.0010
300 TENDERNESS 10 0.0010
301 BURNING SENSATION 67 0.0010
302 SELF-INJURIOUS IDEATION 4 0.0010
303 BREAST CANCER RECURRENT 3 0.0009
304 LABORATORY TEST ABNORMAL 28 0.0009
305 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
306 SERUM FERRITIN INCREASED 5 0.0009
307 RENAL PAIN 10 0.0009
308 BILE DUCT STONE 3 0.0009
309 PRODUCTIVE COUGH 45 0.0009
310 TONGUE DISCOMFORT 4 0.0009
311 ANAEMIA MACROCYTIC 2 0.0009
312 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
313 DYSSTASIA 27 0.0009
314 MUSCULOSKELETAL STIFFNESS 81 0.0009
315 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
316 BLOOD GLUCOSE ABNORMAL 17 0.0009
317 MUSCLE RIGIDITY 11 0.0009
318 PAIN IN JAW 26 0.0009
319 POLLAKIURIA 38 0.0009
320 SINUS DISORDER 18 0.0009
321 NEAR DEATH EXPERIENCE 3 0.0009
322 BLOOD PRESSURE ABNORMAL 18 0.0009
323 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
324 DIABETES MELLITUS INADEQUATE CONTROL 16 0.0009
325 PROSTATE CANCER METASTATIC 3 0.0009
326 HEART RATE ABNORMAL 5 0.0009
327 NECK PAIN 50 0.0009
328 PLANTAR FASCIITIS 3 0.0009
329 MYOCARDIAL INFARCTION 156 0.0009
330 CEREBRAL HAEMATOMA 3 0.0009
331 GOUT 16 0.0009
332 TONGUE ULCERATION 3 0.0009
333 HAEMATOMA 23 0.0009
334 NASAL CONGESTION 52 0.0009
335 COUGH 248 0.0009
336 SECRETION DISCHARGE 11 0.0009
337 BLOOD GLUCOSE INCREASED 165 0.0009
338 INTERNATIONAL NORMALISED RATIO ABNORMAL 3 0.0009
339 CHEST PAIN 161 0.0009
340 DISCOMFORT 53 0.0009
341 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
342 GAIT INABILITY 29 0.0009
343 MOUTH SWELLING 5 0.0009
344 BACK DISORDER 14 0.0009
345 PERFORMANCE STATUS DECREASED 4 0.0009
346 HYPERSENSITIVITY 158 0.0009
347 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
348 HYPERLIPIDAEMIA 10 0.0008
349 PARAESTHESIA ORAL 12 0.0008
350 GUILLAIN-BARRE SYNDROME 4 0.0008
351 FEELING COLD 23 0.0008
352 MONOCYTE COUNT INCREASED 3 0.0008
353 CAROTID ARTERY OCCLUSION 3 0.0008
354 AMYLASE INCREASED 3 0.0008
355 LIP SWELLING 27 0.0008
356 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
357 PROTEIN TOTAL DECREASED 3 0.0008
358 GENERAL PHYSICAL HEALTH DETERIORATION 92 0.0008
359 HEAD DISCOMFORT 14 0.0008
360 APHONIA 11 0.0008
361 DRY THROAT 8 0.0008
362 PARANASAL SINUS HYPERSECRETION 3 0.0008
363 CHEST DISCOMFORT 80 0.0008
364 PRODUCT COLOUR ISSUE 4 0.0008
365 BLOOD CHLORIDE DECREASED 2 0.0008
366 TENDONITIS 12 0.0008
367 GAIT DISTURBANCE 148 0.0008
368 VERTIGO 47 0.0008
369 FAECES HARD 3 0.0008
370 EPIGASTRIC DISCOMFORT 3 0.0008
371 NASOPHARYNGITIS 141 0.0008
372 PERIPHERAL SWELLING 117 0.0008
373 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54 0.0008
374 POLYNEUROPATHY 9 0.0008
375 ABDOMINAL DISCOMFORT 126 0.0008
376 AREFLEXIA 2 0.0007
377 BLOOD SODIUM INCREASED 2 0.0007
378 WRONG PRODUCT ADMINISTERED 5 0.0007
379 ARRHYTHMIA 35 0.0007
380 CHONDROPATHY 2 0.0007
381 EAR CONGESTION 2 0.0007
382 OROPHARYNGEAL PAIN 68 0.0007
383 CHOLESTASIS 14 0.0007
384 DEAFNESS 19 0.0007
385 ONYCHOCLASIS 5 0.0007
386 INJECTION SITE BRUISING 57 0.0007
387 ACUTE PULMONARY OEDEMA 4 0.0007
388 MUSCULOSKELETAL CHEST PAIN 11 0.0007
389 PAPULE 5 0.0007
390 DYSURIA 26 0.0007
391 INJECTION SITE MASS 26 0.0007
392 SCAB 8 0.0007
393 HEPATIC FUNCTION ABNORMAL 26 0.0007
394 PAIN 423 0.0007
395 VASCULITIS 8 0.0007
396 TONGUE DISCOLOURATION 3 0.0007
397 RASH 299 0.0007
398 LIGAMENT RUPTURE 3 0.0007
399 CREPITATIONS 2 0.0007
400 SNEEZING 15 0.0007
401 ATYPICAL PNEUMONIA 2 0.0007
402 MOBILITY DECREASED 48 0.0007
403 HEPATITIS 17 0.0007
404 DYSPNOEA 375 0.0007
405 CRANIOCEREBRAL INJURY 2 0.0007
406 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 119 0.0007
407 HAEMOGLOBIN INCREASED 3 0.0007
408 MEMORY IMPAIRMENT 90 0.0007
409 LOCALISED OEDEMA 3 0.0006
410 PIGMENTATION DISORDER 4 0.0006
411 BACK INJURY 7 0.0006
412 BLOOD BLISTER 2 0.0006
413 ASPIRATION 7 0.0006
414 INJURY ASSOCIATED WITH DEVICE 13 0.0006
415 BLOOD SODIUM DECREASED 12 0.0006
416 INJECTION SITE NODULE 7 0.0006
417 CONTUSION 61 0.0006
418 BLOOD URINE PRESENT 12 0.0006
419 RESPIRATORY TRACT CONGESTION 10 0.0006
420 HYPERTENSIVE CRISIS 7 0.0006
421 FOREIGN BODY SENSATION IN EYES 4 0.0006
422 ABSCESS 10 0.0006
423 NON-SMALL CELL LUNG CANCER 3 0.0006
424 BLOOD PRESSURE FLUCTUATION 15 0.0006
425 SENSORY DISTURBANCE 10 0.0006
426 FRUSTRATION TOLERANCE DECREASED 5 0.0006
427 MUSCLE TIGHTNESS 10 0.0006
428 ATRIAL FIBRILLATION 60 0.0006
429 DERMATITIS CONTACT 7 0.0006
430 BREATH SOUNDS ABNORMAL 3 0.0006
431 LETHARGY 35 0.0006
432 STAPHYLOCOCCAL SEPSIS 3 0.0006
433 HYPERVOLAEMIA 3 0.0006
434 LIGAMENT SPRAIN 6 0.0006
435 IRRITABLE BOWEL SYNDROME 13 0.0006
436 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
437 ABDOMINAL TENDERNESS 3 0.0006
438 DIARRHOEA 389 0.0006
439 HEPATIC ENZYME ABNORMAL 3 0.0006
440 RASH MACULAR 21 0.0006
441 INFLAMMATION 31 0.0006
442 NEUROPATHY PERIPHERAL 57 0.0006
443 QUALITY OF LIFE DECREASED 8 0.0006
444 PRURITUS 228 0.0006
445 SPEECH DISORDER 31 0.0006
446 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
447 SCAR 10 0.0006
448 CERVICAL VERTEBRAL FRACTURE 2 0.0006
449 BLOOD CREATININE ABNORMAL 2 0.0006
450 MUSCLE STRAIN 5 0.0006
451 VENTRICULAR EXTRASYSTOLES 6 0.0006
452 AORTIC STENOSIS 2 0.0006
453 WEIGHT FLUCTUATION 6 0.0006
454 BLISTER 32 0.0006
455 GROIN PAIN 5 0.0006
456 FATIGUE 440 0.0006
457 SCIATICA 9 0.0006
458 TYPE 2 DIABETES MELLITUS 19 0.0006
459 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
460 BREAST PAIN 6 0.0006
461 HYPOAESTHESIA 84 0.0006
462 URTICARIA 94 0.0006
463 FACIAL PAIN 5 0.0006
464 SYNCOPE 56 0.0006
465 PARALYSIS 8 0.0006
466 JAUNDICE 15 0.0006
467 POOR QUALITY SLEEP 12 0.0006
468 SWELLING FACE 36 0.0006
469 COVID-19 97 0.0006
470 HYPERTHYROIDISM 8 0.0006
471 HYPOKINESIA 8 0.0006
472 LIP DRY 5 0.0005
473 ERECTILE DYSFUNCTION 14 0.0005
474 BLOOD PRESSURE INCREASED 83 0.0005
475 BLINDNESS TRANSIENT 4 0.0005
476 TASTE DISORDER 11 0.0005
477 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
478 HYPERKALAEMIA 19 0.0005
479 NERVE COMPRESSION 5 0.0005
480 BLOOD UREA INCREASED 9 0.0005
481 CEREBROVASCULAR ACCIDENT 91 0.0005
482 MIDDLE INSOMNIA 10 0.0005
483 CEREBRAL INFARCTION 13 0.0005
484 HEART RATE IRREGULAR 12 0.0005
485 AUTOIMMUNE THYROIDITIS 2 0.0005
486 HYPERTENSION 112 0.0005
487 HEADACHE 330 0.0005
488 FEELING ABNORMAL 126 0.0005
489 MICTURITION URGENCY 6 0.0005
490 SLEEP DISORDER 37 0.0005
491 FOOD ALLERGY 4 0.0005
492 RASH PRURITIC 28 0.0005
493 ABDOMINAL PAIN LOWER 13 0.0005
494 SWELLING 48 0.0005
495 HEART RATE DECREASED 18 0.0005
496 CHOKING 10 0.0005
497 FAECES DISCOLOURED 11 0.0005
498 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
499 CATARACT 30 0.0005
500 DIZZINESS 251 0.0005
501 INFLUENZA 56 0.0005
502 ABDOMINAL PAIN UPPER 103 0.0005
503 SENSORY LOSS 4 0.0005
504 RHINITIS 4 0.0005
505 RESTLESS LEGS SYNDROME 9 0.0005
506 BURSITIS 6 0.0005
507 PANCREATITIS 26 0.0005
508 ERYTHEMA 101 0.0005
509 GASTROINTESTINAL DISORDER 44 0.0005
510 NEUTROPHIL COUNT INCREASED 5 0.0005
511 METASTASES TO BONE 8 0.0005
512 HICCUPS 4 0.0005
513 CHROMATURIA 11 0.0005
514 EAR DISCOMFORT 5 0.0005
515 PANCREATIC CARCINOMA 14 0.0005
516 MALAISE 212 0.0005
517 AORTIC DISSECTION 2 0.0005
518 CARDIAC DISORDER 45 0.0005
519 HEMIPLEGIA 4 0.0005
520 THROAT TIGHTNESS 13 0.0005
521 ASTHENIA 180 0.0005
522 CHILLS 56 0.0005
523 PERICARDITIS 8 0.0005
524 BLOOD CREATININE INCREASED 31 0.0005
525 SKIN PLAQUE 4 0.0005
526 PARAESTHESIA 74 0.0005
527 PULMONARY MASS 7 0.0005
528 RESPIRATORY DISORDER 14 0.0005
529 ARTHROPATHY 26 0.0005
530 PANIC ATTACK 17 0.0005
531 WEIGHT DECREASED 130 0.0005
532 DEMENTIA 13 0.0005
533 RESTLESSNESS 17 0.0005
534 HYPOAESTHESIA ORAL 7 0.0005
535 SKIN ULCER 12 0.0005
536 APHASIA 14 0.0005
537 CARDIAC MURMUR 4 0.0005
538 CHAPPED LIPS 2 0.0005
539 RESPIRATORY TRACT INFECTION 12 0.0005
540 NEPHROLITHIASIS 21 0.0005
541 DIVERTICULUM INTESTINAL 2 0.0005
542 BLOOD GLUCOSE FLUCTUATION 5 0.0005
543 SPINAL OSTEOARTHRITIS 4 0.0005
544 ANAPHYLACTIC REACTION 25 0.0005
545 LIVER DISORDER 20 0.0005
546 EYE HAEMORRHAGE 6 0.0004
547 SKIN MASS 3 0.0004
548 INJECTION SITE URTICARIA 11 0.0004
549 POST-TRAUMATIC STRESS DISORDER 3 0.0004
550 DRUG-INDUCED LIVER INJURY 14 0.0004
551 BRONCHIECTASIS 3 0.0004
552 LOSS OF LIBIDO 4 0.0004
553 BODY TEMPERATURE INCREASED 9 0.0004
554 CYSTITIS 14 0.0004
555 EAR DISORDER 2 0.0004
556 PNEUMONIA BACTERIAL 4 0.0004
557 PROSTATIC SPECIFIC ANTIGEN INCREASED 6 0.0004
558 JOINT EFFUSION 3 0.0004
559 DROOLING 3 0.0004
560 UROSEPSIS 4 0.0004
561 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
562 SINUSITIS 44 0.0004
563 ERYTHEMA MULTIFORME 4 0.0004
564 DIARRHOEA HAEMORRHAGIC 4 0.0004
565 ALOPECIA 84 0.0004
566 OSTEOARTHRITIS 18 0.0004
567 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
568 THROAT IRRITATION 19 0.0004
569 HAND FRACTURE 3 0.0004
570 EATING DISORDER 9 0.0004
571 JOINT SWELLING 51 0.0004
572 COLITIS 16 0.0004
573 PROTEINURIA 8 0.0004
574 BRONCHOSPASM 6 0.0004
575 SLEEP APNOEA SYNDROME 8 0.0004
576 PALPITATIONS 49 0.0004
577 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
578 INSOMNIA 111 0.0004
579 HYPERCHOLESTEROLAEMIA 4 0.0004
580 FAECES SOFT 3 0.0004
581 DIZZINESS POSTURAL 4 0.0004
582 ABDOMINAL DISTENSION 43 0.0004
583 EAR PAIN 8 0.0004
584 APATHY 6 0.0004
585 PRESYNCOPE 10 0.0004
586 FEELING HOT 25 0.0004
587 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
588 HEPATOMEGALY 4 0.0004
589 ANGIOEDEMA 18 0.0004
590 CEREBRAL DISORDER 3 0.0004
591 NEOPLASM MALIGNANT 27 0.0004
592 IMMUNODEFICIENCY 6 0.0004
593 ANEURYSM 2 0.0004
594 KETOACIDOSIS 3 0.0004
595 LYMPHADENOPATHY 14 0.0004
596 CORONARY ARTERIAL STENT INSERTION 2 0.0004
597 WOUND 11 0.0004
598 TINNITUS 18 0.0004
599 SKIN DISCOLOURATION 18 0.0004
600 INTRAOCULAR PRESSURE INCREASED 5 0.0004
601 RIB FRACTURE 8 0.0004
602 CEREBRAL ISCHAEMIA 2 0.0004
603 TOOTHACHE 7 0.0004
604 GASTROINTESTINAL INFLAMMATION 3 0.0004
605 BLOOD LACTIC ACID INCREASED 2 0.0004
606 SCRATCH 4 0.0004
607 SARS-COV-2 TEST POSITIVE 5 0.0004
608 FURUNCLE 3 0.0004
609 TRICUSPID VALVE INCOMPETENCE 3 0.0004
610 RASH ERYTHEMATOUS 18 0.0004
611 BLOOD PRESSURE DECREASED 25 0.0004
612 HAIR TEXTURE ABNORMAL 5 0.0004
613 OXYGEN SATURATION DECREASED 21 0.0004
614 HEPATIC CIRRHOSIS 7 0.0004
615 STENT PLACEMENT 3 0.0004
616 DYSARTHRIA 14 0.0004
617 FOOT FRACTURE 7 0.0004
618 AMNESIA 24 0.0004
619 MENTAL DISORDER 16 0.0004
620 WOUND INFECTION 4 0.0004
621 VENTRICULAR TACHYCARDIA 6 0.0004
622 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
623 FUNGAL INFECTION 12 0.0004
624 DYSPHONIA 21 0.0004
625 CARPAL TUNNEL SYNDROME 5 0.0004
626 ANGIOPATHY 2 0.0004
627 SENSATION OF FOREIGN BODY 3 0.0004
628 HEMIPARESIS 6 0.0004
629 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
630 CONSTIPATION 77 0.0004
631 FLATULENCE 20 0.0004
632 CIRCULATORY COLLAPSE 6 0.0004
633 FACIAL PARALYSIS 3 0.0004
634 CARDIAC VALVE DISEASE 2 0.0003
635 NEOPLASM 4 0.0003
636 BALANCE DISORDER 30 0.0003
637 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
638 ILL-DEFINED DISORDER 21 0.0003
639 DYSPEPSIA 34 0.0003
640 ADVERSE DRUG REACTION 31 0.0003
641 HOT FLUSH 26 0.0003
642 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 18 0.0003
643 MUCOSAL INFLAMMATION 9 0.0003
644 NEEDLE ISSUE 10 0.0003
645 RENAL DISORDER 16 0.0003
646 URINE OUTPUT DECREASED 3 0.0003
647 GASTROENTERITIS 5 0.0003
648 BLOOD CALCIUM INCREASED 3 0.0003
649 HYPERHIDROSIS 44 0.0003
650 COVID-19 PNEUMONIA 4 0.0003
651 SKIN HAEMORRHAGE 5 0.0003
652 BLOOD IRON DECREASED 4 0.0003
653 ATAXIA 4 0.0003
654 EYE PAIN 19 0.0003
655 CARDIAC FAILURE 27 0.0003
656 THIRST 6 0.0003
657 CHOLECYSTITIS 4 0.0003
658 CARDIAC PACEMAKER INSERTION 2 0.0003
659 DRUG INEFFECTIVE 442 0.0003
660 VISION BLURRED 46 0.0003
661 HAEMORRHAGE 35 0.0003
662 BLOOD GLUCOSE DECREASED 16 0.0003
663 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
664 GASTROENTERITIS VIRAL 6 0.0003
665 VISUAL IMPAIRMENT 41 0.0003
666 VIRAL INFECTION 11 0.0003
667 PELVIC PAIN 6 0.0003
668 URINARY RETENTION 11 0.0003
669 NOCTURIA 4 0.0003
670 LOSS OF CONSCIOUSNESS 42 0.0003
671 DYSPHAGIA 31 0.0003
672 RETINAL DETACHMENT 3 0.0003
673 THYROID DISORDER 5 0.0003
674 ANKLE FRACTURE 5 0.0003
675 CHOLANGITIS 2 0.0003
676 EJECTION FRACTION DECREASED 5 0.0003
677 APPENDICITIS 3 0.0003
678 NERVOUS SYSTEM DISORDER 10 0.0003
679 FLANK PAIN 3 0.0003
680 DERMATITIS ALLERGIC 4 0.0003
681 SPINAL DISORDER 3 0.0003
682 HAEMATEMESIS 8 0.0003
683 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
684 PNEUMOTHORAX 5 0.0003
685 MUSCULOSKELETAL DISORDER 6 0.0003
686 TRANSAMINASES INCREASED 7 0.0003
687 INCREASED APPETITE 6 0.0003
688 HYPOTHYROIDISM 10 0.0003
689 HEART RATE INCREASED 31 0.0003
690 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
691 ENTERITIS 2 0.0003
692 POST PROCEDURAL COMPLICATION 6 0.0003
693 ROTATOR CUFF SYNDROME 4 0.0003
694 THROMBOSIS 25 0.0003
695 SINUS BRADYCARDIA 3 0.0003
696 HERNIA 6 0.0003
697 ANAPHYLACTIC SHOCK 8 0.0003
698 HYPOGLYCAEMIA 15 0.0003
699 BLOOD POTASSIUM INCREASED 5 0.0003
700 PRODUCT AVAILABILITY ISSUE 7 0.0003
701 INFLAMMATORY BOWEL DISEASE 3 0.0003
702 ABDOMINAL PAIN 71 0.0003
703 BEDRIDDEN 4 0.0003
704 APPETITE DISORDER 2 0.0003
705 HYPOTONIA 3 0.0003
706 SKIN DISORDER 10 0.0003
707 JOINT RANGE OF MOTION DECREASED 4 0.0003
708 NAUSEA 236 0.0003
709 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
710 PRODUCT ADMINISTRATION ERROR 6 0.0003
711 SINUS CONGESTION 4 0.0003
712 FEEDING DISORDER 6 0.0003
713 MOTOR DYSFUNCTION 3 0.0003
714 SLUGGISHNESS 3 0.0003
715 PRODUCT PRESCRIBING ERROR 7 0.0003
716 BLOOD TESTOSTERONE DECREASED 2 0.0003
717 DYSPNOEA EXERTIONAL 11 0.0003
718 HELICOBACTER INFECTION 3 0.0003
719 SKIN LESION 8 0.0003
720 PERIPHERAL COLDNESS 4 0.0003
721 TEMPERATURE INTOLERANCE 3 0.0003
722 RESPIRATORY DISTRESS 8 0.0003
723 NIGHTMARE 10 0.0003
724 PETECHIAE 3 0.0003
725 WHEEZING 17 0.0003
726 DERMATITIS 6 0.0003
727 SYRINGE ISSUE 5 0.0003
728 BLOOD TEST ABNORMAL 4 0.0003
729 METASTASES TO LIVER 5 0.0003
730 APPLICATION SITE REACTION 2 0.0003
731 JOINT DISLOCATION 3 0.0003
732 BLINDNESS UNILATERAL 4 0.0003
733 DUODENAL ULCER 2 0.0003
734 MIGRAINE 27 0.0003
735 PYREXIA 97 0.0003
736 IMPAIRED QUALITY OF LIFE 4 0.0003
737 DECREASED ACTIVITY 3 0.0003
738 PNEUMONIA 90 0.0003
739 CELLULITIS 14 0.0003
740 WEIGHT INCREASED 62 0.0003
741 DERMATITIS BULLOUS 2 0.0003
742 IMPAIRED HEALING 9 0.0003
743 RENAL IMPAIRMENT 23 0.0003
744 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 5 0.0003
745 MELAENA 6 0.0003
746 PRODUCT USE IN UNAPPROVED INDICATION 67 0.0003
747 BLINDNESS 11 0.0003
748 TOOTH DISORDER 6 0.0003
749 NERVE INJURY 3 0.0003
750 OSTEOPOROSIS 11 0.0003
751 BLOOD CALCIUM DECREASED 3 0.0003
752 FRACTURE 5 0.0003
753 OSTEOPENIA 4 0.0003
754 GASTRIC ULCER 5 0.0003
755 SKIN EXFOLIATION 22 0.0003
756 ERUCTATION 5 0.0003
757 CONCUSSION 2 0.0003
758 OEDEMA 14 0.0003
759 APHTHOUS ULCER 2 0.0003
760 ORAL HERPES 5 0.0003
761 RHEUMATOID ARTHRITIS 29 0.0003
762 PRODUCT DOSE OMISSION ISSUE 75 0.0003
763 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
764 KIDNEY INFECTION 5 0.0003
765 PRODUCT USE COMPLAINT 4 0.0003
766 HAEMATOCHEZIA 14 0.0003
767 CEREBRAL HAEMORRHAGE 9 0.0003
768 ACCIDENT 3 0.0003
769 HAEMOPTYSIS 7 0.0003
770 BLOOD DISORDER 2 0.0002
771 ECZEMA 13 0.0002
772 HYPERGLYCAEMIA 9 0.0002
773 PULMONARY OEDEMA 11 0.0002
774 HYPERSOMNIA 7 0.0002
775 CARDIOMEGALY 3 0.0002
776 EYE SWELLING 9 0.0002
777 TREMOR 40 0.0002
778 LIVER FUNCTION TEST ABNORMAL 7 0.0002
779 FALL 80 0.0002
780 SKIN IRRITATION 11 0.0002
781 CHRONIC KIDNEY DISEASE 18 0.0002
782 FLUID RETENTION 12 0.0002
783 HYPOPHAGIA 6 0.0002
784 HYPOTENSION 47 0.0002
785 DRY MOUTH 19 0.0002
786 JOINT INJURY 5 0.0002
787 BLOOD POTASSIUM DECREASED 7 0.0002
788 LACRIMATION INCREASED 7 0.0002
789 INJECTION SITE INDURATION 3 0.0002
790 ASTHMA 26 0.0002
791 ORTHOSTATIC HYPOTENSION 4 0.0002
792 ORAL CANDIDIASIS 3 0.0002
793 TOOTH INFECTION 3 0.0002
794 DISORIENTATION 9 0.0002
795 EYE IRRITATION 13 0.0002
796 DRUG ERUPTION 4 0.0002
797 EAR INFECTION 6 0.0002
798 ISCHAEMIC STROKE 4 0.0002
799 RASH PAPULAR 5 0.0002
800 PANCREATITIS ACUTE 5 0.0002
801 ANAL INCONTINENCE 2 0.0002
802 BLOOD BILIRUBIN INCREASED 6 0.0002
803 FREQUENT BOWEL MOVEMENTS 6 0.0002
804 OSTEOMYELITIS 4 0.0002
805 PALLOR 6 0.0002
806 ACUTE HEPATIC FAILURE 3 0.0002
807 LUNG NEOPLASM MALIGNANT 9 0.0002
808 BRAIN NEOPLASM 2 0.0002
809 ORAL DISCOMFORT 3 0.0002
810 RHABDOMYOLYSIS 9 0.0002
811 COORDINATION ABNORMAL 3 0.0002
812 THERAPEUTIC RESPONSE DECREASED 13 0.0002
813 EPISTAXIS 16 0.0002
814 CHOLELITHIASIS 7 0.0002
815 HYPONATRAEMIA 12 0.0002
816 INTENTIONAL DOSE OMISSION 6 0.0002
817 DISEASE RECURRENCE 10 0.0002
818 SKIN BURNING SENSATION 15 0.0002
819 LOWER LIMB FRACTURE 4 0.0002
820 HAEMORRHOIDS 4 0.0002
821 URINARY INCONTINENCE 6 0.0002
822 DRY SKIN 27 0.0002
823 UPPER LIMB FRACTURE 4 0.0002
824 BRAIN INJURY 2 0.0002
825 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
826 LYMPHOMA 3 0.0002
827 DIPLOPIA 5 0.0002
828 THERAPY PARTIAL RESPONDER 3 0.0002
829 HERPES ZOSTER 11 0.0002
830 GASTRITIS 5 0.0002
831 MOUTH ULCERATION 4 0.0002
832 ANXIETY 54 0.0002
833 OCULAR HYPERAEMIA 9 0.0002
834 HEAD INJURY 6 0.0002
835 DECREASED APPETITE 44 0.0002
836 PULMONARY EMBOLISM 18 0.0002
837 DEPRESSED MOOD 10 0.0002
838 ULCER 3 0.0002
839 OBESITY 3 0.0002
840 BODY HEIGHT DECREASED 2 0.0002
841 VOMITING 87 0.0002
842 LUNG DISORDER 9 0.0002
843 PRODUCT PRESCRIBING ISSUE 4 0.0002
844 MOOD ALTERED 5 0.0002
845 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
846 EYE DISORDER 6 0.0002
847 DRY EYE 9 0.0002
848 PROCEDURAL PAIN 5 0.0002
849 DEPRESSION 41 0.0002
850 TACHYCARDIA 16 0.0002
851 DEHYDRATION 24 0.0002
852 STEVENS-JOHNSON SYNDROME 4 0.0002
853 CANDIDA INFECTION 3 0.0002
854 DYSGEUSIA 13 0.0002
855 SHOCK 4 0.0002
856 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
857 COGNITIVE DISORDER 8 0.0002
858 DEEP VEIN THROMBOSIS 11 0.0002
859 DISEASE PROGRESSION 20 0.0002
860 FLUSHING 17 0.0002
861 CONFUSIONAL STATE 27 0.0002
862 DISTURBANCE IN ATTENTION 9 0.0002
863 DIABETIC KETOACIDOSIS 4 0.0002
864 CRYING 6 0.0002
865 MENTAL IMPAIRMENT 4 0.0002
866 DEATH 142 0.0002
867 BONE DISORDER 3 0.0002
868 OEDEMA PERIPHERAL 20 0.0002
869 RECTAL HAEMORRHAGE 7 0.0002
870 PANCYTOPENIA 9 0.0002
871 THINKING ABNORMAL 3 0.0002
872 BACTERIAL INFECTION 3 0.0002
873 PHOTOPHOBIA 3 0.0002
874 SOMNOLENCE 32 0.0002
875 INFECTION 23 0.0002
876 BRAIN OEDEMA 2 0.0002
877 CARDIOVASCULAR DISORDER 4 0.0002
878 PULMONARY FIBROSIS 3 0.0002
879 GLAUCOMA 3 0.0002
880 NIGHT SWEATS 5 0.0002
881 SKIN FISSURES 3 0.0002
882 NERVOUSNESS 8 0.0002
883 ANKYLOSING SPONDYLITIS 2 0.0002
884 CONDITION AGGRAVATED 46 0.0002
885 VISUAL ACUITY REDUCED 5 0.0002
886 ACUTE KIDNEY INJURY 23 0.0002
887 BREAST CANCER 14 0.0002
888 EYE PRURITUS 5 0.0001
889 FEAR 4 0.0001
890 ANGER 5 0.0001
891 DYSKINESIA 6 0.0001
892 LIMB INJURY 4 0.0001
893 HAEMATURIA 5 0.0001
894 HALLUCINATION 11 0.0001
895 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
896 APPLICATION SITE RASH 2 0.0001
897 RENAL FAILURE 19 0.0001
898 HYPOXIA 5 0.0001
899 CARDIOGENIC SHOCK 2 0.0001
900 ANOSMIA 2 0.0001
901 PROSTATE CANCER 11 0.0001
902 HEPATOTOXICITY 3 0.0001
903 ORAL PAIN 3 0.0001
904 APPLICATION SITE PRURITUS 3 0.0001
905 BRADYCARDIA 7 0.0001
906 PERICARDIAL EFFUSION 3 0.0001
907 DELUSION 2 0.0001
908 ACUTE MYELOID LEUKAEMIA 2 0.0001
909 BASAL CELL CARCINOMA 2 0.0001
910 RENAL CANCER 6 0.0001
911 MOOD SWINGS 4 0.0001
912 LOCALISED INFECTION 3 0.0001
913 CARDIAC ARREST 10 0.0001
914 OFF LABEL USE 106 0.0001
915 AGEUSIA 3 0.0001
916 COAGULOPATHY 2 0.0001
917 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
918 ROAD TRAFFIC ACCIDENT 5 0.0001
919 HAEMOGLOBIN DECREASED 12 0.0001
920 GASTRIC DISORDER 4 0.0001
921 DEVICE DEFECTIVE 2 0.0001
922 SEIZURE 13 0.0001
923 CARDIAC FAILURE CONGESTIVE 9 0.0001
924 PAIN OF SKIN 3 0.0001
925 PNEUMONITIS 3 0.0001
926 RESPIRATORY FAILURE 8 0.0001
927 RESPIRATORY ARREST 3 0.0001
928 ABNORMAL DREAMS 3 0.0001
929 INTESTINAL OBSTRUCTION 4 0.0001
930 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
931 RED BLOOD CELL COUNT DECREASED 3 0.0001
932 MULTIPLE SCLEROSIS 5 0.0001
933 ASCITES 3 0.0001
934 RENAL INJURY 3 0.0001
935 DRUG INTERACTION 16 0.0001
936 INJURY 7 0.0001
937 HEPATIC FAILURE 3 0.0001
938 STOMATITIS 6 0.0001
939 PSORIATIC ARTHROPATHY 4 0.0001
940 EPILEPSY 3 0.0001
941 EMOTIONAL DISORDER 3 0.0001
942 GYNAECOMASTIA 3 0.0001
943 FEMUR FRACTURE 3 0.0001
944 TREATMENT FAILURE 8 0.0001
945 HIP FRACTURE 3 0.0001
946 UNEVALUABLE EVENT 7 0.0001
947 STAPHYLOCOCCAL INFECTION 3 0.0001
948 EXPIRED PRODUCT ADMINISTERED 3 0.0001
949 SEPSIS 10 0.0001
950 COLITIS ULCERATIVE 4 0.0001
951 DRUG DOSE OMISSION BY DEVICE 7 0.0001
952 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
953 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
954 INJECTION SITE HAEMORRHAGE 7 0.0001
955 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
956 PLEURAL EFFUSION 5 0.0001
957 THROMBOCYTOPENIA 9 0.0001
958 DRUG RESISTANCE 2 0.0001
959 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
960 PLASMA CELL MYELOMA 3 0.0001
961 PSORIASIS 10 0.0001
962 MUSCULOSKELETAL PAIN 4 0.0001
963 DEVICE DIFFICULT TO USE 5 0.0001
964 INFUSION RELATED REACTION 5 0.0001
965 CARDIO-RESPIRATORY ARREST 3 0.0001
966 INCORRECT DOSE ADMINISTERED 16 0.0001
967 AGITATION 5 0.0001
968 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
969 PLATELET COUNT DECREASED 7 0.0001
970 COMA 3 0.0001
971 AGGRESSION 3 0.0001
972 THERAPY CESSATION 3 0.0001
973 DEVICE ISSUE 5 0.0001
974 ACCIDENTAL OVERDOSE 2 0.0001
975 SUICIDAL IDEATION 5 0.0001
976 ABNORMAL BEHAVIOUR 2 0.0001
977 EMOTIONAL DISTRESS 6 0.0000
978 THERAPY INTERRUPTED 3 0.0000
979 UNDERDOSE 3 0.0000
980 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 8 0.0000
981 PRODUCT USE ISSUE 7 0.0000
982 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
983 ANAEMIA 7 0.0000
984 BLADDER CANCER 2 0.0000
985 ADVERSE EVENT 3 0.0000
986 PRODUCT QUALITY ISSUE 4 0.0000
987 ACNE 2 0.0000
988 HOSPITALISATION 4 0.0000
989 COMPLETED SUICIDE 2 0.0000
990 OVERDOSE 3 0.0000